Alembic FDA Thursday, January 13, 2011 0.00 Neutral

FDA Approves LAMOTRIGINE — Alembic Pharmaceuticals Limited

# FDA Approves Alembic Pharmaceuticals' Generic Lamotrigine Alembic Pharmaceuticals Limited has received FDA approval for its generic lamotrigine oral formulation, expanding the competitive generic market for this widely-used anticonvulsant and mood-stabilizing medication. The approval is expected to provide patients with more affordable treatment options while increasing pricing pressure on branded lamotrigine products.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day